Randomized Placebo Controlled Trial of IVIg in Glycine Receptor Antibody Positive Stiff-person Syndrome

首次发布于 2018 年 11 月 21 日

Antidepressant Effects of the Glycine Receptor Antagonist AV-101 (4-chlorokynurenine) in Major Depressive Disorder

计划入组 22 人 · 首次发布于 2015 年 6 月 29 日

Research Involving Subjects With Parkinson's Disease, Alzheimer Disease and Healthy Controls

计划入组 4 人 · 首次发布于 2011 年 10 月 27 日

Glycine(Aminosyn II 7 %, Sulfite-free, Aminosyn-PF 7%, Clinimix 2.75/5, Clinimix E 2.75/5, Clinisol 15, Freamine 6.9, Freamine III 10, Hepatamine 8, Olimel, Periolimel, Plenamine, Premasol, Primene, Procalamine 3, Prosol, Travasol 10, Trophamine 10 %)

<dd class="col-xl-8 col-md-9 col-sm-8">C₂H₅NO₂</dd>

oral glycine

Ferrous glycine sulfate

C₄H₁₀FeN₂O₈S

Arvinas Estrogen Receptor, Inc.

United States

Arvinas Androgen Receptor, Inc.

United States

VistaGen Therapeutics

United States

Kyverna's CAR-T Therapy for Stiff Person Syndrome Advances to BLA Filing Based on Natural History Study

SLC6A20-Targeting ASO Restores NMDA Receptor Function in Autism Models, Offering New Therapeutic Strategy

DT-109: Novel Glycine-Based Compound Shows Dual Efficacy Against Atherosclerosis and MASH